1. Home
  2. NRK vs XNCR Comparison

NRK vs XNCR Comparison

Compare NRK & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen New York AMT-Free Quality Municipal Income Fund

NRK

Nuveen New York AMT-Free Quality Municipal Income Fund

HOLD

Current Price

$10.18

Market Cap

888.1M

Sector

Finance

ML Signal

HOLD

Logo Xencor Inc.

XNCR

Xencor Inc.

HOLD

Current Price

$12.64

Market Cap

928.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NRK
XNCR
Founded
2002
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
888.1M
928.3M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
NRK
XNCR
Price
$10.18
$12.64
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$22.78
AVG Volume (30 Days)
187.3K
721.7K
Earning Date
01-01-0001
02-26-2026
Dividend Yield
4.10%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$150,132,000.00
Revenue This Year
N/A
$18.68
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
38.16
52 Week Low
$8.95
$6.92
52 Week High
$11.09
$20.09

Technical Indicators

Market Signals
Indicator
NRK
XNCR
Relative Strength Index (RSI) 53.98 36.64
Support Level $10.11 $12.50
Resistance Level $10.19 $13.63
Average True Range (ATR) 0.05 0.73
MACD -0.01 -0.05
Stochastic Oscillator 41.67 8.44

Price Performance

Historical Comparison
NRK
XNCR

About NRK Nuveen New York AMT-Free Quality Municipal Income Fund

Nuveen New York AMT-Free Quality Municipal Income Fund is a closed-end investment company. The Fund seeks to provide current income exempt from regular federal, New York State, and New York City income taxes, and from the federal alternative minimum tax for individuals, while enhancing portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds considered underrated, undervalued, or from undervalued municipal market sectors. It may invest in municipal securities such as lease obligations and certificates of participation, which provide an undivided interest in pools of municipal leases or installment purchase agreements.

About XNCR Xencor Inc.

Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.

Share on Social Networks: